Scientists make bowel and liver cancer treatment breakthrough
Scientists have had a breakthrough in treatment for bowel and liver cancer
Researchers at the Cancer Research UK Scotland Institute in Glasgow have identified new potential treatments to suppress the growth of bowel and liver cancers.
The study focused on genetic errors that hijack the WNT pathway, a signalling system that controls cell growth, leading to tumour development.
They discovered that a protein called nucleophosmin (NPM1) is found at high levels in bowel and some liver cancers due to these genetic faults.
Blocking NPM1, which is not essential for healthy adult tissue, could offer a safe and effective way to treat specific hard-to-treat bowel and liver cancers.
This breakthrough, part of the Cancer Grand Challenges initiative, aims to develop more personalised treatments, with future research focusing on drugs to block NPM1 production.